Market Overview

GE Healthcare Life Sciences Announces KUBio Modular Biopharmaceutical Factory to be Built in China for JHL Biotech

GE
Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE), and JHL
Biotech, a provider of biopharmaceutical process development and
manufacturing services, today announced that a KUBio™
modular biopharmaceutical factory will be built in China for JHL
Biotech. The site for the new factory, which will be fully operational
beginning early 2015, is the Biolake Science Park in Wuhan, China.

GE Healthcare's KUBio™ modular biopharmaceutical factory (Photo: Business Wire)

Worldwide demand for biopharmaceuticals, such as antibodies for the
treatment of cancer and a new generation of innovative vaccines, is
increasing dramatically. KUBio is a new approach to readily establish
biopharmaceutical manufacturing capacity by delivering customers a fully

See full press release

Posted-In: News Guidance Contracts Management Global

 

Related Articles (GE)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional